Candesic partner Dr Michelle Tempest harnessing the potential of Artificial Intelligence
2 June 2023Candesic Senior Partner and author of “Big Brain Revolution: Artificial Intelligence Spy or Saviour?" Dr Michelle Tempest shared her knowledge…Digital health market set for shake-out
16 May 2023Amid continued double-digit growth in digital healthcare, the competitive landscape is expected to consolidate over coming years. Dr Michelle Tempest,…How bright is the future for Digital Therapeutics across Europe?
11 May 2023Candesic Senior Partners Marc Kitten and Dr Michelle Tempest cover rapidly growing DTx Europe market in the newest ImpactX2050 report…Metaverse for Healthcare
30 March 2023Tomorrow 31st March 3PM (UK time) join Candesic Senior Partner Dr Michelle Tempest on Twitter Space "Metaverse for Healthcare" in…The art of E-prescribing
25 August 2022E-prescribing has the potential to improve patient safety and reduce provider costs. It has been identified by the NHS as…Why are Fintech Merger & Acquisitions on the rise in 2022?
21 July 2022Candesic's Partner, Marc Kitten, has been quoted in the FinTech Magazine. He commented "the merger and acquisitions boom is a…Digital clinical trials in a new era
6 April 2022Dr Michelle Tempest, Partner and George Holden from Candesic are excited to share their thoughts on ‘digital clinical trials’. The…Opportunities to blow your mind
22 December 2020For all those wanting to beat the blues before Christmas and get some of Candesic’s clear thinking in these chaotic…Best Practices: Scaling in Healthtech
27 November 2020Candesic's Dr Michelle Tempest was the panelist at "Best Practices: Scaling in Healthtech", hosted by The Healthtech Exchange. Michelle has…Digital transmission
9 June 2020The Candesic team published in this month's LaingBuisson Healthcare Markets Journal about the digital disruption occurred in the primary care…